Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD

ClinicalTrials.gov ID: NCT06267560

Public ClinicalTrials.gov record NCT06267560. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 5:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Pelacarsen (TQJ230) in US Black/African American & Hispanic Patient Populations With Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study CTQJ230A12303 is a randomized, double-blind placebo-controlled, Phase IIIb study to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) 80 mg s.c. QM compared with placebo s.c. QM in US Black/African American and Hispanic participants with established ASCVD and elevated levels of Lp(a) who are treated for cardiovascular (CV) risk factors according to local practice/guidelines for the reduction of cardiovascular risk.

Study identification

NCT ID
NCT06267560
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
422 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 24, 2024 (Actual)
Primary completion
Mar 25, 2026 (Actual)
Completion
Mar 25, 2026 (Actual)
Last update posted
Aug 10, 2026

2024 – 2026

United States locations

U.S. sites
89
U.S. states
20
U.S. cities
72
Facility City State ZIP Site status
Parkway Medical Center Birmingham Alabama 35215 —
Cardiology and Medicine Clinic PA Little Rock Arkansas 72204 —
National Heart Institute Beverly Hills California 90211 —
Alliance Clinical Canoga Park California 91303 —
Valley Clinical Trials Inc Covina California 91723 —
NICRs Research Center Garden Grove California 92844 —
University of Calif Irvine Med Cntr Irvine California 92660 —
Long Beach Clinical Trials Long Beach California 90806 —
Angel City Research Inc Los Angeles California 90026 —
California Medical Research Associates Inc Northridge California 91324 —
Stanford University Medical Center Palo Alto California 94304 —
Acclaim Clinical Research San Diego California 92120 —
Excel Medical Clinical Trials LLC Boca Raton Florida 33434 —
C and A Clinical Trials Cape Coral Florida 33990 —
Proactive Clinical Research Fort Lauderdale Florida 33308 —
National Research Institute Hialeah Florida 33013 —
Sister Life Research Inc Hialeah Florida 33013 —
Zenith Clinical Research Hollywood Florida 33021 —
Columbus Clinical Services LLC Miami Florida 33125 —
Finlay Medical Research Miami Florida 33126 —
Infinite Clinical Research Miami Florida 33133 —
Flourish Research Miami LLC Miami Florida 33135 —
International Research Associates LLC Miami Florida 33156 —
Baptist Health South Miami Florida 33173 —
A&A Research Group Inc Miami Florida 33186 —
Inpatient Research Clinical LLC Miami Lakes Florida 33014 —
FXM Clin Res Miramar LLC Miramar Florida 33027 —
CTMD Research Palm Springs Florida 33406 —
DBC Research USA Pembroke Pines Florida 33029 —
New Tampa Health Tampa Florida 33603 —
James A Haley Veterans Hospital Tampa Florida 33612 —
Cardiology Partners Clinical Research Institute Wellington Florida 33449 —
Flourish Research Winter Park Florida 32789 —
Morehouse School Of Medicine Atlanta Georgia 30310 —
Atlanta Heart Specialists LLC Tucker Georgia 30084 —
Synexus Clinical Research US Inc Chicago Illinois 60602 —
Chicago Clinical Research Inst Chicago Illinois 60607 —
Cardiovascular Associates Research Covington Louisiana 70433 —
Omega Clinical Research Metairie Louisiana 70006 —
CV Ins of the South Opelousas Louisiana 70570 —
Monroe Research Llc West Monroe Louisiana 71291 —
Southern Clin Research Clinic Zachary Louisiana 70791 —
Sinai Ct for Throm Res and Drug Dev Baltimore Maryland 21209 —
Ascension Saint Agnes Heart Care Baltimore Maryland 21229 —
Johns Hopkins Univ School of Med Baltimore Maryland 21287 —
Metropolitan Cardiovascular Consultants Llc Beltsville Maryland 20705 —
Johns Hopkins University Columbia Maryland 21044 —
Anderson Medical Research Ft. Washington Maryland 20744 —
Capitol Cardiology Associates Lanham Maryland 20706 —
MD Medical Research Oxon Hill Maryland 20745 —
Henry Ford Hospital Detroit Michigan 48202 —
Aa Mrc Mhs Flint Michigan 48503 —
Aa Mrc Llc Flint Michigan 48504 —
Elite Clinical Research LLC Jackson Mississippi 39202 —
Stern Cardiovascular Foundation Inc Southaven Mississippi 38671 —
Las Vegas Endocrinology Henderson Nevada 89074 —
AB Clinical Trials Las Vegas Nevada 89119 —
Clinical Research of South Nevada Las Vegas Nevada 89121 —
Robert Wood Johnson Medical School New Brunswick New Jersey 08901 —
Overlook Medical Center Summit New Jersey 07901 —
Jamaica Hospital Medical Center Richmond Hill New York 11418 —
Monroe Biomedical Research Monroe North Carolina 28112 —
Alliance Medical Ministry Raleigh North Carolina 27610 —
Velocity Clin Research Springdale Cincinnati Ohio 45246 —
NexGen Research Lima Ohio 45801 —
Care Access Research Easton Pennsylvania 18045 —
TCV Clinical Studies Linwood Pennsylvania 19061 —
The Stern Cardiovascular Foundation Germantown Tennessee 38138 —
Apex Cardiology Research Associates of Jackson Jackson Tennessee 38301 —
Plano Primary Care Clinic Allen Texas 75002-3688 —
Pharma Tex Research Amarillo Texas 79106 —
North Hills Medical Research Inc Bedford Texas 76021 —
SW Family Medicine Associates Dallas Texas 75235 —
David Turbay MD PLLC El Paso Texas 79905 —
Ctr for Clin Rsch and Innovatn Houston Texas 77008 —
Angiocardiac Care of Texas PA Houston Texas 77025 —
Dallas Heart and Vascular Consultants PA Houston Texas 77084 —
Epic Clinical Research Lewisville Texas 75057 —
The Heart Institute of East Texas Lufkin Texas 75904 —
Discovery Clinical Trials Pflugerville Texas 78660-3015 —
University of Texas Health Science Ctr San Antonio Texas 78229-3900 —
Clinical Trials of Texas San Antonio Texas 78229 —
Sugar Lakes Family Practice Sugar Land Texas 77479 —
Javara Research Alexandria Virginia 22311 —
Virginia Heart Falls Church Virginia 22042 —
Heart Care Associates P C Hopewell Virginia 23860 —
Dominion Medical Associates Richmond Virginia 23219 —
Virginia Commonwealth University Richmond Virginia 23298-0111 —
University of Washington Seattle Washington 98195 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06267560, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 10, 2026 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06267560 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →